Microbot Medical Stock
Microbot Medical Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Harel Gadot
- Employees
- 43
- Market cap
- $64 M
- IPO
- 25/03/1992
Microbot Medical Inc. operates as a pre-clinical stage medical device company, concentrating its efforts on the research, design, and development of robotic instruments for endoluminal surgery, specifically targeting the field of minimally invasive procedures. Leveraging its proprietary micro-robotic technologies,…
Microbot Medical stock: price history
1D
+0.0%
1W
-11.2%
1M
-34.0%
6M
-59.4%
YTD
-52.5%
1Y
-66.5%
2Y
-5.0%
5Y
-86.8%
10Y
-99.2%
Next earnings date
Next earnings date
11/11/2026 (in 25 days)
Volatility around earnings
~20% stronger price swings than usual
Ask the agents about Microbot Medical
Analyst assessment of Microbot Medical
PRICE TARGET LOW
US$4.00
CONSENSUS
US$4.00
MEDIAN
US$4.00
PRICE TARGET HIGH
US$4.00
0
STRONG BUY
3
BUY
1
HOLD
0
SELL
0
STRONG SELL
4
TOTAL · Buy
As of: 14/08/2026
Microbot Medical stock metrics
P/E
-3.64
P/B
0.93
EV/EBITDA
-3.78
RETURN ON EQUITY
-8.2%
NET MARGIN
-2,334.9%
DEBT/EQUITY
0.01
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
90.9%
FLOAT SHARES
61,025,736
AVG. DAILY VOLUME (30D)
655,154
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Microbot Medical stock
What does Microbot Medical do?
Microbot Medical Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Harel Gadot, the company employs around 43 people.
The IPO was on 25/03/1992; the stock trades on NASDAQ under the ticker MBOT.
What do analysts say about Microbot Medical stock?
4 analysts rate the stock, the consensus is Buy (as of 14/08/2026).
The average price target is US$4.00, ranging from US$4.00 to US$4.00, with a median of US$4.00.
This is an external assessment, not a statement by Market Jury.
When does Microbot Medical report next?
The next earnings date is 11/11/2026.
Around past earnings, price swings were roughly 20% stronger than usual.
Does Microbot Medical pay a dividend?
No, Microbot Medical currently does not pay a dividend.
Which stocks are comparable to Microbot Medical?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Microbot Medical stock analyzed?
Clicking "Analyze stock" lets five strategies assess Microbot Medical against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.